Left ventricular hypertrophy and the risk of subsequent left ventricular remodeling following myocardial infarction.

[1]  H. White,et al.  Remodeling after myocardial infarction: An opportunity for early intervention , 1997, Basic Research in Cardiology.

[2]  G. Lamas,et al.  Left ventricular remodeling: clinical significance and therapy , 1997, Basic Research in Cardiology.

[3]  S. Solomon,et al.  The decreasing incidence of left ventricular remodeling following myocardial infarction , 1997, Basic Research in Cardiology.

[4]  O. Carretero,et al.  Effects of pre-existing left ventricular hypertrophy on ventricular dysfunction and remodeling following myocardial infarction in rats. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  S. Solomon,et al.  Recovery of Ventricular Function after Myocardial Infarction in the Reperfusion Era: The Healing and Early Afterload Reducing Therapy Study , 2001, Annals of Internal Medicine.

[6]  D. Antoniucci,et al.  Doppler-derived mitral deceleration time: an early strong predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction. , 1999, Circulation.

[7]  S. Solomon,et al.  Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: where we stand today. , 1998, American heart journal.

[8]  G. Blackwell,et al.  Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction. , 1998, American heart journal.

[9]  B. Jugdutt,et al.  Limitation of Left Ventricular Hypertrophy and Dysfunction by ACE Inhibition after Anterior Q-Wave Myocardial Infarction , 1998, Cardiology.

[10]  G. Lamas,et al.  Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. , 1997, Circulation.

[11]  S. Solomon,et al.  Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. , 1997, Circulation.

[12]  S. Kawashima,et al.  Effects of chronic hypertension and left ventricular hypertrophy on the extent of infarct expansion in rats. , 1996, American journal of hypertension.

[13]  C. Slager,et al.  Early identification of patients at risk for significant left ventricular dilation one year after myocardial infarction. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  G. Lamas,et al.  Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.

[15]  L. Rossi,et al.  Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. , 1994, The American journal of cardiology.

[16]  Peter Gaudron,et al.  Progressive Left Ventricular Dysfunction and Remodeling After Myocardial Infarction Potential Mechanisms and Early Predictors , 1993, Circulation.

[17]  U. Goldbourt,et al.  Long-term prognosis after acute myocardial infarction in patients with left ventricular hypertrophy on the electrocardiogram☆ , 1992 .

[18]  D. Levy,et al.  Prognostic significance of the electrocardiogram after Q wave myocardial infarction. The Framingham Study. , 1990, Circulation.

[19]  R. Kleiger,et al.  Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction. , 1988, The American journal of cardiology.